Clinical Trial Update: Randomized Phase 2 Study of Atezolizumab and Entinostat in Patients With aTN Breast Cancer With Phase 1b Lead In [Phase 1, Phase 2]

View source ↗

Summary

A randomized Phase 2 study evaluating the combination of atezolizumab and entinostat in advanced triple-negative breast cancer with a Phase 1b lead-in has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Drugs mentioned

• Entinostat (entinostat)
• Tecentriq (atezolizumab)

Snippet

Sponsor: Syndax Pharmaceuticals | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-09-14